Page last updated: 2024-08-23

selegiline and Psychoses, Drug

selegiline has been researched along with Psychoses, Drug in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Arakawa, R; Cselényi, Z; Elmore, CS; Farde, L; Halldin, C; Johnström, P; Kingston, L; Moein, MM; Nag, S; Stepanov, V; Varnäs, K	1
Hollán, S; Magyar, K; Vécsei, L	1

Other Studies

2 other study(ies) available for selegiline and Psychoses, Drug

Article	Year
The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans. Neuropharmacology, 2020, 01-01, Volume: 162 Topics: Adult; Allosteric Regulation; Animals; Binding Sites; Brain; Carbon Radioisotopes; Female; Humans; Imidazoles; Macaca fascicularis; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Oximes; Positron-Emission Tomography; Psychoses, Substance-Induced; Pyridines; Radiopharmaceuticals; Receptor, Metabotropic Glutamate 5; Selegiline; Young Adult	2020
Adverse effects of dopamine potentiation by long-term treatment with selegiline. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Basal Ganglia Diseases; Blood Platelets; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Genotype; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Huntingtin Protein; Long-Term Care; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurologic Examination; Neuroprotective Agents; Nuclear Proteins; Polymerase Chain Reaction; Proteins; Psychoses, Substance-Induced; Reference Values; Selegiline; Trinucleotide Repeats	2004

Article

Year

The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.

Neuropharmacology, 2020, 01-01, Volume: 162

Topics: Adult; Allosteric Regulation; Animals; Binding Sites; Brain; Carbon Radioisotopes; Female; Humans; Imidazoles; Macaca fascicularis; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Oximes; Positron-Emission Tomography; Psychoses, Substance-Induced; Pyridines; Radiopharmaceuticals; Receptor, Metabotropic Glutamate 5; Selegiline; Young Adult

2020

Adverse effects of dopamine potentiation by long-term treatment with selegiline.

Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1

Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Basal Ganglia Diseases; Blood Platelets; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Genotype; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Huntingtin Protein; Long-Term Care; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurologic Examination; Neuroprotective Agents; Nuclear Proteins; Polymerase Chain Reaction; Proteins; Psychoses, Substance-Induced; Reference Values; Selegiline; Trinucleotide Repeats

2004